Skip to main content

Table 2 Clinical characteristics of patients

From: Human neural stem cell transplantation in ALS: initial results from a phase I trial

Patient (Code) Group Age Sex ALS-FRS-R Score FVC Disease duration at entry Follow up duration
      (%) (Months from symptoms onset) (Months from surgery to death (†) or to the last visit)
740 A1 30 M 25 74 60 18
746 A1 57 M 28 64 68 8†
753 A1 54 F 29 83 16 8†
766 A2 35 M 30 82 72 12
767 A2 67 F 35 88 36 8†
779 A2 38 M 24 82 24 7
  1. A1; unilateral hNSCs microinjections.
  2. A2; bilateral hNSCs microinjections.
  3. †; death.